Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. Its modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.